As the world continues to grapple with the COVID-19 pandemic, many people are seeking potential treatments to protect themselves and their love ones from the virus. One drug that has gain attention in recent months is ivermectin, a medication that has use for decades to treat parasitic infections in humans and animals. However, there has been widespread debate and controversy surrounding the use of ivermectin and ivermectin buy online as a preventative or treatment option for COVID-19. In this blog post, we will delve into the scientific evidence and separate fact from fiction when it comes to taking ivermectin as need for COVID.
What is Ivermectin?
Ivermectin is a medication that was first introduce in the 1980s. It is primarily use to treat parasitic infections cause by roundworms, threadworms, and other parasites. It is commonly prescribed for conditions such as river blindness and intestinal strongyloidiasis. Ivermectin works by paralyzing and killing the parasites, thus preventing them from reproducing and spreading in the body.
Ivermectin 3 mg tablets and COVID-19 Amid the COVID-19 pandemic, some studies and anecdotal reports have suggests that it may have potential antiviral properties against SARS-CoV-2, the virus that causes COVID-19. Proponents of ivermectin argue that it could be a game-changer in the fight against the virus, claiming that it can prevent infection, reduce the severity of symptoms, and lower the risk of hospitalization and death.
However, it is important to note that the evidence on the use of this pill for COVID-19 is still limit and inconclusive. While some studies have promising results in test tubes and animal models, the quality of evidence from clinical trials in humans is often low, with small sample sizes, methodological flaws, and conflicting findings. The majority of reputable health organizations and regulatory agencies, including the World Health Organization (WHO), the U.S. Food and Drug Administration (FDA), and the National Institutes of Health (NIH), currently do not recommend the routine use of this pill for COVID-19 outside of clinical trials or under emergency use authorization.
Risks and Safety Concerns
Like any medication, ivermectin also comes with potential risks and safety concerns. While it is generally well-tolerate at the doses use to treat parasitic infections, the safety profile of ivermectin when use for COVID-19 is not fully understood, especially at higher doses or for long-term use. Some of the potential risks associate with ivermectin include:
Drug interactions:
Ivermectin can interact with other medications, including blood-thinning drugs, anti-seizure medications, and certain antibiotics, potentially leading to adverse effects or reduce effectiveness of these medications.
Side effects:
Common side effects of ivermectin include nausea, vomiting, diarrhea, dizziness, and skin rash. In rare cases, it can cause more serious side effects such as liver injury, allergic reactions, and neurological disorders.
Overdose:
Taking too much of pill can result in an overdose, which can cause symptoms such as low blood pressure, rapid heart rate, and even coma or death. Overdose is more likely to occur when using ivermectin formulations that are intended for animals, as these can have higher concentrations of the drug.
Lack of regulatory approval:
As mention earlier, it has not approve by most health authorities for the prevention or treatment of COVID-19,
